IL138977A0 - Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth - Google Patents

Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth

Info

Publication number
IL138977A0
IL138977A0 IL13897799A IL13897799A IL138977A0 IL 138977 A0 IL138977 A0 IL 138977A0 IL 13897799 A IL13897799 A IL 13897799A IL 13897799 A IL13897799 A IL 13897799A IL 138977 A0 IL138977 A0 IL 138977A0
Authority
IL
Israel
Prior art keywords
neuropilin
methods
same
cell growth
antisense oligonucleotide
Prior art date
Application number
IL13897799A
Other languages
English (en)
Original Assignee
Genesense Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesense Technologies Inc filed Critical Genesense Technologies Inc
Publication of IL138977A0 publication Critical patent/IL138977A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13897799A 1998-04-23 1999-04-24 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth IL138977A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8279198P 1998-04-23 1998-04-23
PCT/CA1999/000324 WO1999055855A2 (en) 1998-04-23 1999-04-23 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth

Publications (1)

Publication Number Publication Date
IL138977A0 true IL138977A0 (en) 2001-11-25

Family

ID=22173486

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13897699A IL138976A0 (en) 1998-04-23 1999-04-23 Insulin-like growth factor ii antisense oligonucleotide sequences adn methods of using same to modulate cell growth
IL13897799A IL138977A0 (en) 1998-04-23 1999-04-24 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL13897699A IL138976A0 (en) 1998-04-23 1999-04-23 Insulin-like growth factor ii antisense oligonucleotide sequences adn methods of using same to modulate cell growth

Country Status (11)

Country Link
US (2) US6417169B1 (xx)
EP (2) EP1073728A2 (xx)
JP (2) JP2002512792A (xx)
KR (2) KR20010042849A (xx)
CN (2) CN1298445A (xx)
AU (2) AU747639C (xx)
BR (2) BR9909809A (xx)
CA (2) CA2326824A1 (xx)
IL (2) IL138976A0 (xx)
NZ (2) NZ508353A (xx)
WO (2) WO1999055855A2 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040006220A1 (en) * 2002-07-02 2004-01-08 Isis Pharmaceuticals Inc. Antisense modulation of insulin-like growth factor 2 expression
US6316259B1 (en) * 2000-01-21 2001-11-13 Isis Pharmaceuticals, Inc. Antisense inhibition of glycogen synthase kinase 3 alpha expression
US6653467B1 (en) * 2000-04-26 2003-11-25 Jcr Pharmaceutical Co., Ltd. Medicament for treatment of Duchenne muscular dystrophy
AUPR030900A0 (en) * 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
KR100441201B1 (ko) * 2001-09-10 2004-07-23 대한민국 리포터 유전자를 포함하는 티벡터용 플라스미드 및 그 제조방법
EP1439192A1 (en) * 2003-01-15 2004-07-21 Xerion Pharmaceuticals AG Neuropilin-1 inhibitors
EP2270159B1 (en) 2003-05-21 2015-01-07 Andes Biotechnologies S.A. Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
WO2005049648A2 (en) * 2003-07-09 2005-06-02 The University Of Iowa Research Foundation Chimeric or fusion constructs of insulin-like growth factor binding proteins as chemotherapeutic agents
EP1661582A1 (en) * 2003-08-21 2006-05-31 Kyowa Hakko Kogyo Co., Ltd. Cancer metastasis inhibitor
US20060193772A1 (en) * 2003-09-24 2006-08-31 Atsushi Ochiai Drugs for treating cancer
KR100818332B1 (ko) * 2006-03-21 2008-04-02 퓨리메드 주식회사 녹용으로부터 분리된 신규 인슐린 유사 성장 인자 2의 폴리펩타이드 및 이의 유전자
CA2687247A1 (en) * 2007-05-17 2008-11-27 Genentech, Inc. Inhibition of tumor metastasis by anti neuropilin 2 antibodies
KR20120003187A (ko) * 2010-07-02 2012-01-10 한국생명공학연구원 Ｎｅｕｒｏｐｉｌｉｎ １ 유전자를 이용한 천식 진단 및 천식 치료제 스크리닝 방법
EP2522341A1 (en) 2011-05-13 2012-11-14 Tragex Pharma Pharmaceutical compositions comprising Neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers
EP2997373A1 (en) * 2013-05-17 2016-03-23 MedImmune, LLC Receptors for b7-h4
EP2823816A1 (en) 2013-07-09 2015-01-14 Tragex Pharma Inhibitors of Neuropilin and use thereof for the treatment of Neuropilin-related diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5225347A (en) 1989-09-25 1993-07-06 Innovir Laboratories, Inc. Therapeutic ribozyme compositions and expression vectors
US5766855A (en) 1991-05-24 1998-06-16 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity and sequence specificity
US5719262A (en) 1993-11-22 1998-02-17 Buchardt, Deceased; Ole Peptide nucleic acids having amino acid side chains
US5665544A (en) * 1992-05-27 1997-09-09 Amersham International Plc RNA fingerprinting to determine RNA population differences
WO1994008625A1 (en) 1992-10-21 1994-04-28 Temple University - Of The Commonwealth System Of Higher Education Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer
US6346398B1 (en) * 1995-10-26 2002-02-12 Ribozyme Pharmaceuticals, Inc. Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
US6391311B1 (en) * 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
AU1810499A (en) * 1997-12-09 1999-06-28 Children's Medical Center Corporation Antagonists of neuropilin receptor functional and use thereof

Also Published As

Publication number Publication date
EP1073728A2 (en) 2001-02-07
AU3402299A (en) 1999-11-16
BR9909859A (pt) 2000-12-19
US20020187954A1 (en) 2002-12-12
IL138976A0 (en) 2001-11-25
AU747639C (en) 2005-01-13
CA2326825A1 (en) 1999-11-04
WO1999055854A3 (en) 2000-06-29
AU749802B2 (en) 2002-07-04
WO1999055855A3 (en) 2000-01-06
JP2002512792A (ja) 2002-05-08
KR20010042848A (ko) 2001-05-25
WO1999055854A2 (en) 1999-11-04
NZ508354A (en) 2005-01-28
KR20010042849A (ko) 2001-05-25
US6417169B1 (en) 2002-07-09
CA2326824A1 (en) 1999-11-04
AU747639B2 (en) 2002-05-16
BR9909809A (pt) 2000-12-19
NZ508353A (en) 2005-01-28
EP1073729A2 (en) 2001-02-07
AU3402199A (en) 1999-11-16
JP2002512793A (ja) 2002-05-08
CN1298445A (zh) 2001-06-06
WO1999055855A2 (en) 1999-11-04
CN1298444A (zh) 2001-06-06

Similar Documents

Publication Publication Date Title
IL138977A0 (en) Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
IL108367A0 (en) Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells
HUP0102598A3 (en) Expression of trehalose biosynthetic genes in plants
ZA986822B (en) Reduction of hair growth
EP1003916A4 (en) ANTI-SENSE OLIGONUCLEOTID COMPOSITIONS AND METHODS FOR MODULATING JNK PROTEINS
HUP0103571A3 (en) Characterisation of gene function using double stranded rna inhibition
IL129710A0 (en) Method of raising fish by use of algal turf
EP0975649A4 (en) RNASE L ACTIVATORS AND ANTISENSE OLIGONUCLEOTIDES FOR THE EFFECTIVE TREATMENT OF Vicious TUMORS
EP1082456A4 (en) ANTISENSE MODULATION OF THE CD40 EXPRESSION
ZA988641B (en) Reduction of hair growth
EP1119365A4 (en) COMPOSITIONS AND METHODS FOR USING TUMOR CELLS
AU3249897A (en) Oligonucleotides from the untranslated regions of housekeeping genes and methods of using same to modulate cell growth
AU3563199A (en) Seed specific polycomb group gene and methods of use for same
AU9509798A (en) Antisense oligonucleotide compositions targeted to angiotensi n converting enzy me mrna and methods of use
AU8327798A (en) Antisense oligonucleotide sequences as inhibitors of microorganisms
IL138580A0 (en) Plant promoter sequences and methods of use thereof
IL137177A0 (en) Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
HUP0302908A3 (en) Genes and methods for manipulation of growth
EP1054979A4 (en) COMPOSITIONS AND METHODS FOR SENSITIZING AND INHIBITING GROWTH OF HUMAN CANCER CELLS
AU4224999A (en) Antisense oligonucleotide modulation of human thymidylate synthase expression
EP1085892A4 (en) VACCINE STRATEGY FOR THE PREVENTION AND TREATMENT OF CANCER
GB9721396D0 (en) Improvements in or relating to growth of microorganisms
IL141473A0 (en) Method to enhance and confine expression of genes
AU2585197A (en) Antisense approach to gene inhibition
EP1126854A4 (en) BENZOAZEPINES AND THEIR ANALOGS AS MEANS THAT PROMOTE THE SECRETION OF THE GROWTH HORMONE